Future work includes deploying the sensors to detect a panel of biomarkers for the early detection of AD (such as ApoE, Aβ, etc.)using a novel multiplexing platform we are currently developing, which will be reported in a future study. This evidence concerns the gene APOE and Alzheimer disease.